Tonix Pharmaceuticals Holding Corp.·5

Feb 12, 5:32 PM ET

SAENGER BRADLEY 5

5 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 12, 2021

Insider Transaction Report

Form 5
Period: 2020-12-31
SAENGER BRADLEY
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2020-01-06$1.02/sh+493$5031,397 total
Footnotes (1)
  • [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2019 Employee Stock Purchase Plan.

Documents

1 file
  • 5
    tnxp-form5_123120.xmlPrimary

    ANNUAL STATEMENT OF CHANGES IN OWNERSHIP